United States · FDA National Drug Code directory
Orphenadrine Citrate, Aspirin and Caffeine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71993-307_415b66fb-2d59-f2f0-e063-6394a90a4318
- Product NDC
- 71993-307
- Form
- TABLET
- Composition / generic term
- Orphenadrine Citrate, Aspirin and Caffeine
- Labeler
- Atland Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230301
- Source listing expiry
- 20261231
Source-listed ingredients
- ORPHENADRINE CITRATE — 50 mg/1
- ASPIRIN — 770 mg/1
- CAFFEINE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE, PLASTIC (71993-307-60) · 71993-307-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →